WILMINGTON — ChristianaCare has spun out its first commercial biotech company focused on gene-editing technology to develop new cancer treatments. CorriXR Therapeutics launched Tuesday with $5 million in seed funding […]
Even after 20 years of leading research into gene-editing techniques and applications, ChristianaCare’s Gene Editing Institute continues to advance the science. Examples include recently pioneering a new technique to better […]
CHRISTIANA – Eric Kmiec has studied molecular medicine and gene editing for 30 years, but he’s rarely seen a time when the fruits of research are so readily at hand. […]
Delaware bioscience companies and boosters will showcase the state’s strength at the international BIO Convention in Philadelphia from June 3 to 6. The annual event is expected to draw 18,000 […]
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.